Greenrise Global Brands Inc.

Equities

XCX

CA39540L1085

Pharmaceuticals

Delayed Canadian Securities Exchange 10:35:35 2024-04-15 am EDT 5-day change 1st Jan Change
0.005 CAD -66.67% Intraday chart for Greenrise Global Brands Inc. 0.00% -50.00%

This article is reserved for members

Already a member?

Log In

Not a member ?

Free registration
Greenrise Global Brands Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023 CI
Greenrise Global Brands Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023 CI
Greenrise Global Brands Inc. Reports Earnings Results for the First Quarter Ended March 31, 2023 CI
Greenrise Global Brands Inc. Reports Earnings Results for the Full Year Ended December 31, 2022 CI
Greenrise Global Brands Inc. Auditor Raises 'Going Concern' Doubt CI
An unknown buyer acquired a 31% stake in CannaCare Health GmbH from Greenrise Global Brands Inc. for €0.3875 million. CI
An unknown buyer acquired AMP Alternative Medical Products GmbH from Greenrise Global Brands Inc. for €0.59 million. CI
Greenrise Global Brands Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2022 CI
An unknown buyer acquired 20% stake in CannaCare Health GmbH from Greenrise Global Brands Inc. for €0.25 million. CI
Greenrise Global Brands Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2022 CI
Greenrise Global Brands Highlights Preliminary Sales for Q2; Developments regarding the Legislation of Adult-Use Cannabis in Germany MT
Greenrise Global Brands Inc. Announces Unaudited Sales Results for the Second Quarter 2022 CI
Greenrise Global Brands Inc. Reports Earnings Results for the First Quarter Ended March 31, 2022 CI
Greenrise Global Brands Inc. Appoints Frank Otto to the Board of Directors CI
Greenrise Global Brands Inc. Auditor Raises 'Going Concern' Doubt CI
Greenrise Global Brands Inc. Reports Earnings Results for the Full Year Ended December 31, 2021 CI
Greenrise Global Brands Inc. announced that it has received CAD 0.7234 million in funding CI
Greenrise Global Jumped Near 20% From Near 52 Week Low Levels After Buying Majority Stake in CannaCare MT
Greenrise Global Brands Up 16.7% after Reporting Purchase of Majority Stake in CannaCare Health MT
Greenrise Global Brands Inc. to Appoint Frank Otto to its Board of Directors CI
Greenrise Global Brands Inc. acquired 51% stake in CannaCare Health GmbH from its co-founders Frank Otto and the Oplesch family (CannaCare Shareholders) €3.02 million. CI
Greenrise Global Brands Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2021 CI
Greenrise Global Brands Welcomes Germany's Legalization of Cannabis for Adults MT
Greenrise Global Brands Inc. Launches Herbify CBD Wellness Brand in Germany CI
Greenrise Global Brands Inc. announced that it expects to receive CAD 0.35 million in funding CI
Chart Greenrise Global Brands Inc.
More charts
Greenrise Global Brands Inc. is a Canada-based investment holding company with investments in the cannabis industry in Germany. The Company, through CannaCare Health GmbH (CannaCare), offers a range of approximately 20 cannabidiol (CBD) products consisting of tinctures, sprays and oils and skincare products made from natural raw materials manufactured in Europe and Germany and distributed through traditional sales channels, such as www.cannacare-health.com and www.canobo.de. CannaCare is a producer and supplier of CBD wellness products and wholly owns AMP Alternative Medical Products GmbH (AMP), an importer and distributor of European Union-Good Manufacturing Practice (EU-GMP) medical cannabis to pharmacies.
More about the company
  1. Stock Market
  2. Equities
  3. XCX Stock
  4. News Greenrise Global Brands Inc.
  5. Greenrise Global Brands Welcomes Germany's Legalization of Cannabis for Adults